Adage Capital Partners Portfolio holdings
AUM
$59.3B
1-Year Return
26.26%
This Quarter Return
+6.76%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$41.2B
AUM Growth
+$286M
(+0.7%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-4.19%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
795
New
95
Increased
203
Reduced
357
Closed
88
Top Buys
| 1 |
DuPont de Nemours
DD
|
$209M |
| 2 |
Parker-Hannifin
PH
|
$140M |
| 3 |
Bunge Global
BG
|
$137M |
| 4 |
Chemours
CC
|
$130M |
| 5 |
Deere & Co
DE
|
$124M |
Top Sells
| 1 |
GE Aerospace
GE
|
$233M |
| 2 |
Honeywell
HON
|
$173M |
| 3 |
Spirit AeroSystems
SPR
|
$153M |
| 4 |
Dover
DOV
|
$142M |
| 5 |
Danaher
DHR
|
$129M |
Sector Composition
| 1 | Healthcare | 15.08% |
| 2 | Technology | 14.14% |
| 3 | Financials | 13% |
| 4 | Industrials | 10.13% |
| 5 | Consumer Discretionary | 9.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
Nutanix
NTNX
$18.7B
| $5.04M | 0.01% |
+225,000
| New | +$5.04M |
|
|
DCPH
627
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $4.75M | 0.01% |
+250,000
| New | +$4.75M |
|
628
Kellanova
K
$27.8B
| $4.72M | 0.01% |
80,660
-642,940
| -89% | -$37.7M |
|
|
DISCA
629
DELISTED
Discovery, Inc. Series A Common Stock
DISCA
| $4.69M | 0.01% |
+220,103
| New | +$4.69M |
|
|
CFRX
630
DELISTED
ContraFect Corporation
CFRX
| $4.55M | 0.01% |
5,125
+2,000
| +64% | +$1.78M |
|
|
ESL
631
DELISTED
Esterline Technologies
ESL
| $4.52M | 0.01% |
+50,164
| New | +$4.52M |
|
632
Teva Pharmaceuticals
TEVA
$21.7B
| $4.4M | 0.01% |
+250,000
| New | +$4.4M |
|
633
Cencora
COR
$56.7B
| $4.37M | 0.01% |
52,800
-182,100
| -78% | -$15.1M |
|
634
Halozyme
HALO
$8.76B
| $4.34M | 0.01% |
250,000
-75,000
| -23% | -$1.3M |
|
|
635
Spirit AeroSystems
SPR
$4.8B
| $4.32M | 0.01% |
55,554
-1,962,707
| -97% | -$153M |
|
|
MANT
636
DELISTED
Mantech International Corp
MANT
| $4.26M | 0.01% |
96,397
| – | – |
|
637
Tenaris
TS
$18.2B
| $4.25M | 0.01% |
150,000
-250,000
| -63% | -$7.08M |
|
638
KALA BIO
KALA
$102M
| $4.15M | 0.01% |
+3,635
| New | +$4.15M |
|
|
NXTM
639
DELISTED
NxStage Medical Inc.
NXTM
| $4.14M | 0.01% |
+150,000
| New | +$4.14M |
|
|
SRCL
640
DELISTED
Stericycle Inc
SRCL
| $4M | 0.01% |
55,800
-17,300
| -24% | -$1.24M |
|
641
Acushnet Holdings
GOLF
$4.49B
| $3.92M | 0.01% |
220,508
| – | – |
|
642
Dollar General
DG
$24.1B
| $3.68M | 0.01% |
+45,423
| New | +$3.68M |
|
643
AtriCure
ATRC
$1.76B
| $3.68M | 0.01% |
164,353
+50,000
| +44% | +$1.12M |
|
644
Neurogene
NGNE
$285M
| $3.55M | 0.01% |
+12,500
| New | +$3.55M |
|
|
MRNS
645
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $3.52M | 0.01% |
+150,000
| New | +$3.52M |
|
|
AMRN
646
Amarin Corp
AMRN
$317M
| $3.5M | 0.01% |
50,000
| – | – |
|
647
Pentair
PNR
$18.1B
| $3.4M | 0.01% |
74,450
-165,001
| -69% | -$7.53M |
|
648
Western Union
WU
$2.86B
| $3.39M | 0.01% |
176,693
-81,900
| -32% | -$1.57M |
|
649
argenx
ARGX
$45.9B
| $3.39M | 0.01% |
150,000
| – | – |
|
|
ADAP
650
Adaptimmune Therapeutics
ADAP
$10.9M
| $3.35M | 0.01% |
408,901
-50,000
| -11% | -$410K |
|